RESEARCHER PROFILE (Filmed May 2024)
Dr Matthew Wallen PhD, AES, AEP
Senior Research Fellow, Caring Futures Institute
College of Nursing and Health Sciences
Flinders University,
South Australia
Dr Matthew Wallen PhD, AES, AEP is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program, and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University, in South Australia. His clinical interest focuses on improving outcomes for people requiring major surgery, specifically (1) lifestyle interventions, including exercise, nutritional, and psychological support to improve the health and wellbeing of people prior to surgery, termed ‘prehabilitation’, (2) novel physical function assessments aimed at identifying people at risk of treatment-related complications, and (3) implementation of new models of care in cancer.
Since graduating from his PhD in 2017, Dr Wallen has published over 55 peer-reviewed articles, including international guidelines and position statements in cancer care and lifestyle-related conditions, in high-impact international journals such as CA: a Journal for Clinicians and The Lancet’s eClinicalMedicine. He has attracted more than AUD$10 million in research income and has supervised research projects for 7 PhD students (1 completed, 6 on-going), 21 Master’s students (completed), and 3 honours students (completed). Dr Wallen is the Course Coordinator for the Master of Clinical Exercise Physiology at Flinders University, and currently advises for the Exercise and Sport Science Australia Research Committee and South Australian State Chapter.
Source: Supplied
* AES is the acronym for Accredited Exercise Scientist (AES), AEP is the acronym for Accredited Exercise Physiologist
-
Dr Jade Murray
DR JADE MURRAY, POSTDOCTORAL RESEARCH FELLOW
TURNER INSTITUTE FOR BRAIN AND MENTAL HEALTH, MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Mental health research on first responders in regional, rural and remote Australia
Dr Rikki Jones has been awarded to date a total of over $430,000 in research funding. She is currently leading four large national research teams focusing on rural health and sustainable rural health workforce (include mental health of first responders, sexual violence in rural Australia, virtual simulated nursing placements, and nursing students experience with online learning, connection and transitioning to practice).
